History | Atezolizumab for treating locally advanced or metastatic urothelial carcinoma after platinum-containing chemotherapy | Guidance | NICE

History

Documents created during the development process.

Expected publication

Equality Impact Assessment (Guidance development) (PDF 237 KB)

Published:

13 June 2018

Final appraisal determination

Final appraisal determination
Committee papers (PDF 1.01 MB)

Published:

17 May 2018
Public committee slides (PDF 420 KB)

Published:

17 May 2018
Final appraisal determination document (PDF 115 KB)

Published:

17 May 2018

Draft guidance

Draft guidance
Appraisal consultation document (PDF 384 KB)

Published:

22 December 2017
Public committee slides (PDF 820 KB)

Published:

22 December 2017
Committee papers (PDF 3.88 MB)

Published:

22 December 2017

Draft guidance: 1

Draft guidance: 1
Committee papers (PDF 16.21 MB)

Published:

28 September 2017
Public committee slides (PDF 8.96 MB)

Published:

28 September 2017
Appraisal consultation document (PDF 361 KB)

Published:

28 September 2017

Invitation to participate

Final scope (PDF 55 KB)

Published:

28 September 2017
Final matrix (PDF 177 KB)

Published:

28 September 2017
NICE's response to comments on the draft scope and provisional matrix (PDF 210 KB)

Published:

28 September 2017